NCT03503864Active, not recruitingPhase 2
Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma
Clinical Research on Efficacy and Safety of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma：A Prospective，Single-arm, Open-label, Multi-center Study
Source: ClinicalTrials.gov · Last updated 21 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This clinical trial aims to explore and evaluate the efficacy and safety of combined chemotherapy with arsenic trioxide for stage 4/M neuroblastoma.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 21 Jan 2018
- Start date
- 12 Jun 2017
- Primary completion date
- 30 Aug 2023
- Lead sponsor
- Yang Li
- Diseases
- Neuroblastoma, Childhood cancers
- NCT number
- NCT03503864
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 80
- From 12 Jun 2017 to the primary completion date, 30 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who had suffered from other tumors and received chemotherapy or abdominal radiotherapy.
Other illness
- Patients with one or more critical organs failure such as heart, brain, kidney failure.
Who the study is looking for
- Untreated Stage 4/M neuroblastoma patients according to the International Neuroblastoma Staging System（INSS) or the International Neuroblastoma Risk Group (INRG) staging system;
- Patients not more than 14 years old;
- There are measurable lesions;
- Guardians agreed and signed informed consent.
Age in the registry: - to 14 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.